IV iron dosing regimens: choice of agent and dosing frequency.
作者信息
Winkelmayer Wolfgang C
出版信息
Nephrol News Issues. 2014 Feb;28(2):10-1, 18.
PMID:24649746
Abstract
摘要
相似文献
1
IV iron dosing regimens: choice of agent and dosing frequency.静脉铁剂给药方案：药物选择及给药频率
Nephrol News Issues. 2014 Feb;28(2):10-1, 18.
2
Implementing an IV iron administration protocol within a dialysis organization.在透析机构内实施静脉铁剂给药方案。
Nephrol News Issues. 2014 Feb;28(2):19-21.
3
How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysis.如何减少慢性透析患者促红细胞生成素刺激剂的使用？：通过补充铁剂减少血液透析中促红细胞生成素刺激剂的剂量
Semin Dial. 2013 Sep-Oct;26(5):534-6. doi: 10.1111/sdi.12105. Epub 2013 Jun 14.
4
More than a decade of experience and still no consensus: controversies in iron therapy.十多年的经验积累，却仍未达成共识：铁剂治疗中的争议
Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S1-3. doi: 10.2215/CJN.02030606.
5
Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial.比较三种蔗糖铁铁维持方案在儿童、青少年和年轻成人 CKD 患者中的安全性和疗效：一项随机对照试验。
Am J Kidney Dis. 2013 Apr;61(4):588-97. doi: 10.1053/j.ajkd.2012.10.019. Epub 2012 Dec 12.
6
Non-intravenous approaches to iron therapy in chronic kidney disease: will it improve the benefit-to-risk ratio?慢性肾脏病中铁剂治疗的非静脉途径：它会改善风险效益比吗？
Nephrol News Issues. 2014 Feb;28(2):12, 14-5.
7
Intravenous iron therapy in non-dialysis CKD patients.非透析慢性肾脏病患者的静脉铁剂治疗
Nephrol Dial Transplant. 2014 Apr;29(4):717-20. doi: 10.1093/ndt/gft419. Epub 2013 Dec 5.
8
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.静脉注射羧甲麦芽糖铁对比标准医学治疗用于治疗慢性肾脏病患者的缺铁性贫血：一项随机、活性对照、多中心研究。
Nephrol Dial Transplant. 2013 Apr;28(4):953-64. doi: 10.1093/ndt/gfs528. Epub 2012 Dec 5.
9
How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The "forgotten adjunct therapy": the link between ESA use and control of hyperparathyroidism in chronic kidney disease.
Semin Dial. 2013 Sep-Oct;26(5):537-40. doi: 10.1111/sdi.12106. Epub 2013 Jun 5.
10
The iron story: red smoke and magnetism?铁的故事：红色烟雾与磁性？
Nephrol News Issues. 2014 Feb;28(2):2-3.
Zotero 插件